Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 16, 2020 12:00 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience to Participate in Canaccord Genuity Virtual MedTech & Diagnostics Forum

CINCINNATI, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today that Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and...
November 13, 2020 07:30 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience Reports Strong Fourth Quarter and Record Full-Year Fiscal 2020 Operating Results and Provides Fiscal 2021 Guidance

CINCINNATI, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fourth quarter and fiscal year ended September 30, 2020. ...
October 20, 2020 11:00 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call on November 13, 2020

CINCINNATI, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report fourth quarter and full...
October 07, 2020 09:00 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience Launches a Complete Solution to Support Liquid Biopsy Cancer Diagnostics

CINCINNATI, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading provider of diagnostic testing solutions and life science raw materials, announced today that it has...
September 14, 2020 10:00 ET | Source: Meridian Bioscience Inc.

Meridian launches a novel SARS-CoV-2 antibody pair designed for developing highly sensitive rapid antigen tests from saliva samples

CINCINNATI, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading provider of diagnostic testing solutions and life science critical raw materials, is pleased to...
August 31, 2020 08:00 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience to Present at the H. C. Wainright 22nd Annual Global Investment Conference

CINCINNATI, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today that Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and...
August 07, 2020 07:30 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience Reports Fiscal Third Quarter 2020 Operating Results – Best Quarter in Company History – Raises Full Year Guidance

CINCINNATI, Aug. 07, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fiscal third quarter ended June 30, 2020. Third Quarter Fiscal...
July 28, 2020 09:00 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience Announces New Board Member - Anthony Bihl

CINCINNATI, July 28, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announces the appointment of Anthony Bihl III to its Board of Directors, effective immediately. “We welcome...
July 16, 2020 09:00 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience to Hold Third Quarter 2020 Financial Results Conference Call on August 7, 2020

CINCINNATI, July 16, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report third quarter 2020...
July 13, 2020 13:00 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience Announces the Launch of a High-Sensitivity SARS-CoV-2 Nucleocapsid Antibody Pair for the Development of Rapid COVID-19 Antigen Assays

CINCINNATI, July 13, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading provider of diagnostic testing solutions and life science raw materials, announced today that it has...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right